Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Targeting protein for Xklp2 (TPX2) is a microtubule-associated spindle assembly factor required for the nucleation and organization of microtubules during mitosis and meiosis[1][2][3][4]. It interacts with tubulin to stimulate microtubule nucleation, coordinates spindle assembly around chromosomes, and is regulated by the Ran-GTP-importin pathway[1][2][4]. TPX2 activates and recruits Aurora A kinase to the spindle, is necessary for proper bipolar spindle formation, and participates in both de novo and branching microtubule nucleation[1][2][3][4][5]. In cancer, TPX2 is often overexpressed, making it a proliferation-associated marker and potential prognostic biomarker in several malignancies; however, no direct drug targets or approved therapies against TPX2 exist at present[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Targeting protein for Xklp2 (TPX2).